About: Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (en) Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (nl)
skos:prefLabel	Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (en) Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (nl)
name	Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (en) Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients (nl)
title	wds:Q65470431-F049557A-5A79-421C-9193-35864AB9C87D
title	Imatinib Mesylate, Busulfan, Fludarabine, Antithymocyte Globulin and Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia (en)
end time	wds:Q65470431-C9BE7F7D-78D5-480B-ABD4-3AF9B82A2D27
end time	2009-11-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65470431-5F864D57-3598-410D-B77C-639072C71EC0
instance of	clinical trial
start time	wds:Q65470431-F3C9F697-DB1F-422E-B4AE-6EE676A2DD3B
start time	2003-02-01 00:00:00Z (xsd:dateTime)
country	wds:Q65470431-61D665B2-AFD0-43E0-869A-FDD3BB1D1346
country	United States of America
research site	wds:Q65470431-8B371D91-DD15-4FF3-B3C8-6A5B69FD858A
research site	University of Texas at Houston Police Department
research intervention	wds:Q65470431-AFB0C0E6-C63B-4556-B2E9-544D29499EA4
research intervention	fludarabine phosphate
medical condition	wds:Q65470431-2AF25C72-0F02-416A-868E-62A0A0703097
medical condition	leukemia
number of participants	wds:Q65470431-63134428-82E2-41E9-BB48-9266BA7EE280
number of participants	42 (xsd:decimal)
maximum age	wds:Q65470431-580874C3-CE67-4B04-AF0D-2B17FE504E14
maximum age	70 (xsd:decimal)
study type	wds:Q65470431-FFC578E6-9B50-4732-AA17-AA228D41C40A
study type	interventional study
ClinicalTrials.gov ID	wds:Q65470431-44310D6C-1BA8-4E1E-86AF-246B203AC55F
ClinicalTrials.gov ID	NCT00499889
clinical trial phase	wds:Q65470431-64CECFD7-F4C4-4F46-9FEA-7292255216C5
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65470431

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software